India's Natco Pharma gains on new drug application for generic lung cancer tablet

Natco Pharma

30/08/2024 05:39

** Shares of Natco Pharma  NATP.NS  up 4.3%; top gainer on
pharma index  .NIPHARM , which is up 1%
    ** Co on Thursday said it filed new drug application to U.S.
Food & Drug Administration for generic version of Tabrecta
tablets
    ** Drug used to treat lung cancer had sales of $126 mln in
U.S in 2023, co said
    ** NATP up 92% YTD, second biggest gainer among 20 stocks in
pharma index, which is up 37%



 (Reporting by Sethuraman NR in Bengaluru)
 ((Sethuraman.NR@thomsonreuters.com; (+91 9945291420); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))